Overview and key metrics (USD, unless stated otherwise):
- Revenue: Not disclosed in the provided data set ( Revenue field = null across the QQ2 2024 period).
- Operating Income:
• Amount: -$26,916 for QQ2 2024
• QoQ: +54.24% (improvement versus prior quarter)
• YoY: -4.52% (decline versus year-ago period)
- Net Income:
• Amount: -$29,776 for QQ2 2024
• QoQ: +51.73% (improvement versus prior quarter)
• YoY: -17.27% (decline versus year-ago period)
- EPS (diluted): -$0.0003 for QQ2 2024
• QoQ: +57.14% (sequential improvement in loss per share)
• YoY: 0.00%
- EBITDA: -$26,916 for QQ2 2024 (reflecting constrained operating performance)
- Cash Flow:
• Net cash from operating activities: -$47,391
• Free cash flow: -$47,391
• Net change in cash: +$8,234 (driven by financing activity)
• Cash at end of period: $10,339; Cash at beginning: $2,105
• Common stock issued: $55,625 (financing activity)
- Balance sheet snapshot (USD):
• Total assets: $10,339
• Total liabilities: $274,296
• Total stockholders’ equity: -$263,957 (negative equity)
• Cash and equivalents: $10,339; Debt: $171,000; Net debt: $160,661
• Current ratio: 0.0546; Quick ratio: 0.0546; Cash ratio: 0.0546 (extremely tight liquidity)
- Leverage and profitability indicators:
• Debt-to-equity: -0.648 (negative equity skews traditional leverage metrics)
• P/B ratio: -44.22; P/E ratio: -98.00 (negative due to net losses)
• EV multiple: -439.62 (reflects negative enterprise value with current pricing dynamics)
• Interest coverage: -9.41 (negative earnings relative to interest expense)
• Return on assets (ROA): -2.88%; Return on equity (ROE): 11.3% (contextual given negative equity; ROE appears elevated due to small equity base)
• All four-quarter trailing data indicate volatility in profitability and liquidity, with a notable reliance on equity financing to shore up cash